Rohan R Walvekar1,2, Pedro A Andrade Filho1, Raja R Seethala3, William E Gooding4, Dwight E Heron5, Jonas T Johnson1, Robert L Ferris1,6. 1. Department of Otolaryngology, University of Pittsburgh School of Medicine and Cancer Institute, Pittsburgh, PA 15213. 2. Departments of Otolaryngology Head & Neck Surgery, LSU Health Sciences Center, New Orleans, LA 70112. 3. Pathology, University of Pittsburgh School of Medicine and Cancer Institute, Pittsburgh, PA 15213. 4. Biostatistics, University of Pittsburgh School of Medicine and Cancer Institute, Pittsburgh, PA 15213. 5. Radiation Oncology, University of Pittsburgh School of Medicine and Cancer Institute, Pittsburgh, PA 15213. 6. Immunology, University of Pittsburgh School of Medicine and Cancer Institute, Pittsburgh, PA 15213.
Abstract
BACKGROUND: The aim of this study, using a retrospective chart review as the primary study design, was to determine the relative contribution of clinicopathologic risk factors versus low- and high-risk grade histologic groups to assist management of primary parotid cancers. METHODS: In all, 168 primary parotid malignancies were treated surgically at a tertiary care center from 1982 to 2005. Of these, 115 patients with complete follow-up information were further analyzed. Pathologic updating and reclassification in 28% of cases enabled comparison of tumor histology or grade with current consensus criteria. Clinical outcomes of high- and low-risk histology and grade were compared with the influence of traditional clinicopathologic risk factors. RESULTS: Of 115 cases, the male:female ratio was equal and the median age was 63 years (range, 15 to 89 years). Mucoepidermoid carcinoma (n = 28) was the most common histology. The median follow-up was 44 months (range, 0–278 months). Of low-risk histology patients who underwent neck dissection 40% had pN+ disease. The median time to recurrence was not reached for low-risk tumors, compared with 29 months for high-risk tumors (p = .0001). Interestingly, extracapsular spread (ECS) and margin status were independent prognostic factors and conferred significantly greater prognostic value than histologic grade risk group. Disease-free survival (DFS) and overall survival (OS) at 5 years for the entire cohort were 51% and 57%, respectively. Risk group was a strong independent predictor of OS but not DFS. CONCLUSIONS: Risk group defined by histology and grade was associated with DFS. ECS and margin status were independent predictors of DFS. Inclusion of ECS and margin status substantially improved the prediction of disease recurrence, supporting elective neck dissection and postoperative radiotherapy for high-grade tumors or low-risk histologies with positive margins or ECS.
BACKGROUND: The aim of this study, using a retrospective chart review as the primary study design, was to determine the relative contribution of clinicopathologic risk factors versus low- and high-risk grade histologic groups to assist management of primary parotid cancers. METHODS: In all, 168 primary parotid malignancies were treated surgically at a tertiary care center from 1982 to 2005. Of these, 115 patients with complete follow-up information were further analyzed. Pathologic updating and reclassification in 28% of cases enabled comparison of tumor histology or grade with current consensus criteria. Clinical outcomes of high- and low-risk histology and grade were compared with the influence of traditional clinicopathologic risk factors. RESULTS: Of 115 cases, the male:female ratio was equal and the median age was 63 years (range, 15 to 89 years). Mucoepidermoid carcinoma (n = 28) was the most common histology. The median follow-up was 44 months (range, 0–278 months). Of low-risk histology patients who underwent neck dissection 40% had pN+ disease. The median time to recurrence was not reached for low-risk tumors, compared with 29 months for high-risk tumors (p = .0001). Interestingly, extracapsular spread (ECS) and margin status were independent prognostic factors and conferred significantly greater prognostic value than histologic grade risk group. Disease-free survival (DFS) and overall survival (OS) at 5 years for the entire cohort were 51% and 57%, respectively. Risk group was a strong independent predictor of OS but not DFS. CONCLUSIONS: Risk group defined by histology and grade was associated with DFS. ECS and margin status were independent predictors of DFS. Inclusion of ECS and margin status substantially improved the prediction of disease recurrence, supporting elective neck dissection and postoperative radiotherapy for high-grade tumors or low-risk histologies with positive margins or ECS.
Authors: Vincent L M Vander Poorten; Augustinus A M Hart; Bernardus F A M van der Laan; Robert J Baatenburg de Jong; Johannes J Manni; Henri A M Marres; Cees A Meeuwis; Herman Lubsen; Chris H J Terhaard; Alfonsus J M Balm Journal: Cancer Date: 2003-03-15 Impact factor: 6.860
Authors: Peter Zbären; Jonas Schüpbach; Michel Nuyens; Edouard Stauffer; Richard Greiner; Rudolf Häusler Journal: Am J Surg Date: 2003-07 Impact factor: 2.565
Authors: Eberhard Stennert; Dilek Kisner; Markus Jungehuelsing; Orlando Guntinas-Lichius; Ursula Schröder; Hans Edmund Eckel; Jens Peter Klussmann Journal: Arch Otolaryngol Head Neck Surg Date: 2003-07
Authors: Chris H J Terhaard; H Lubsen; I Van der Tweel; F J M Hilgers; W M H Eijkenboom; H A M Marres; R E Tjho-Heslinga; J M A de Jong; J L N Roodenburg Journal: Head Neck Date: 2004-08 Impact factor: 3.147
Authors: Markus Stenner; Christoph Molls; Jan C Luers; Dirk Beutner; Jens P Klussmann; Karl-Bernd Huettenbrink Journal: Eur Arch Otorhinolaryngol Date: 2011-06-14 Impact factor: 2.503
Authors: Mark R Gilbert; Arun Sharma; Nicole C Schmitt; Jonas T Johnson; Robert L Ferris; Umamaheswar Duvvuri; Seungwon Kim Journal: JAMA Otolaryngol Head Neck Surg Date: 2016-05-01 Impact factor: 6.223
Authors: Serena A Byrd; Matthew E Spector; Thomas E Carey; Carol R Bradford; Jonathan B McHugh Journal: Otolaryngol Head Neck Surg Date: 2013-05-21 Impact factor: 3.497
Authors: Glenn J Hanna; Ji Eun Bae; Jochen H Lorch; Robert I Haddad; Vickie Y Jo; Jonathan D Schoenfeld; Danielle N Margalit; Roy B Tishler; Laura A Goguen; Donald J Annino; Nicole G Chau Journal: Oncologist Date: 2020-04-20
Authors: Rocío Sánchez-Burgos; Teresa Gonzalez Otero; Luis Lassaletta; Javier Arias Gallo; Ignacio Navarro Cuellar; Miguel Burgueño García Journal: Ann Maxillofac Surg Date: 2015 Jul-Dec